The role of genomics in tracking the evolution of influenza A virus

PLoS Pathogens

Volumn 5, Issue 10, 2009, Pages

  McHardy, Alice Carolyn ^a   Adams, Ben ^b  

^a MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; MATRIX PROTEIN; PA PROTEIN; PB1 PROTEIN; PB2 PROTEIN; PROTEIN M2; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; VIRUS RNA; VIRUS SIALIDASE; VIRUS ANTIGEN;

ANTIGENIC VARIATION; GENETIC REASSORTMENT; GENETIC VARIABILITY; GENOMICS; IMMUNE RESPONSE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; MOLECULAR EVOLUTION; MOLECULAR MODEL; NONHUMAN; REVIEW; VIRION; VIRUS GENOME; VIRUS MUTATION; VIRUS STRAIN; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

ANTIGENS, VIRAL; EVOLUTION, MOLECULAR; GENOMICS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN;

EID: 70350486533     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000566     Document Type: Review

References (66)

1. WHO (2003) Fact sheet number 211. Available: http://www.who.int/ mediacentre/factsheets/fs211/en/. Accessed 13 August 2009.
2. Viboud C, Alonso WJ, Simonsen L (2006) Influenza in tropical regions. PLoS Med 3: e89. doi:10.1371/journal.pmed.0030089.
3. Palese P (2004) Influenza: old and new threats. Nat Med 10: S82-87.
4. Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9-14.
5. Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-421.
6. Morens DM, Taubenberger JK, Fauci AS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361: 225-229.
7. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
8. Horimoto T, Kawaoka Y (2005) Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3: 591-600.
9. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, et al. (2005) Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437: 1162-1166.
10. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
11. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822.
12. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619.
13. Wolf YI, Viboud C, Holmes EC, Koonin EV, Lipman DJ (2006) Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct 1: 34.
14. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
15. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 324: 1557-1561.
16. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
17. Wilson IA, Cox NJ (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737-771.
18. Wilson IA, Skehel JJ, Wiley DC (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289: 366-373.
19. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, et al. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455: 532-536.
20. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26(Suppl 4): D31-34.
21. Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, et al. (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6: 143-155.
22. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD (2000) Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61: 94-99.
23. CDC (2004) Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine - Colorado, December 2003. MMWR Morb Mortal Wkly Rep 53: 8-11.
24. Salzberg S (2008) The contents of the syringe. Nature 454: 160-161.
25. Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, et al. (2006) Large-scale sequence analysis of avian influenza isolates. Science 311: 1576-1580.
26. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
27. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320: 340-346.
28. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
29. Enserink M (2007) Data sharing. New Swiss influenza database to test promises of access. Science 315: 923.
30. Bogner P, Capua I, Lipman DJ, Cox NJ, et al. (2006) A global initiative on sharing avian flu data. Nature 442: 981.
31. Fitch WM, Leiter JM, Li XQ, Palese P (1991) Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A 88: 4270-4274.
32. Fitch WM, Bush RM, Bender CA, Cox NJ (1997) Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A 94: 7712-7718.
33. Bush RM, Fitch WM, Bender CA, Cox NJ (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16: 1457-1465.
34. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205.
35. Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, et al. (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303: 327-332.
36. Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, et al. (2006) Stochastic processes are key determinants of short-term evolution in influenza A virus. PLoS Pathog 2: e125. doi:10.1371/journal.ppat.0020125.
37. Lowen AC, Palese P (2007) Influenza virus transmission: Basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets 7: 318-328.
38. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, et al. (2006) Host species barriers to influenza virus infections. Science 312: 394-397.
39. Johnson NP, Mueller J (2002) Updating the accounts: Global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76: 105-115.
40. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, et al. (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437: 889-893.
41. Reid AH, Taubenberger JK, Fanning TG (2004) Evidence of an absence: The genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol 2: 909-914.
42. Antonovics J, Hood ME, Baker CH (2006) Molecular virology: Was the 1918 flu avian in origin? Nature 440: E9; discussion E9-10.
43. Taubenberger JK (2006) The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc 150: 86-112.
44. Smith GJ, Bahl J, Vijaykrishna D, Zhang J, Poon LL, et al. (2009) Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 106: 11709-11712.
45. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125.
46. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
47. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
48. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature;E-pub ahead of print. doi:10.1038/nature08260.
49. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, et al. (2005) Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 3: e300. doi:10.1371/ journal.pbio.0030300.
50. Nelson MI, Edelman L, Spiro DJ, Boyne AR, Bera J, et al. (2008) Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog 4: e1000133. doi:10.1371/journal.-ppat. 1000133.
51. Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, et al. (2008) Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4: e1000012. doi:10.1371/journal.ppat.1000012.
52. Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC (2007) Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog 3: e131. doi:10.1371/journal.ppat.0030131.
53. Fitch WM, Bush RM, Bender CA, Subbarao K, Cox NJ (2000) The Wilhelmine E. Key 1999 Invitational lecture. Predicting the evolution of human influenza A. J Hered 91: 183-185.
54. Gupta V, Earl DJ, Deem MW (2006) Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 24: 3881-3888.
55. Blackburne BP, Hay AJ, Goldstein RA (2008) Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 4: e1000058. doi:10.1371/journal.ppat.1000058.
56. Kryazhimskiy S, Bazykin GA, Plotkin J, Dushoff J (2008) Directionality in the evolution of influenza A haemagglutinin. Proc Biol Sci 275: 2455-2464.
57. Pybus OG, Rambaut A (2009) Modelling: Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10: 540-550.
58. Bishop CM (2006) Pattern recognition and machine learning. In: Jordan M, Kleinberg J, Schoellkopf B, eds. , Singapore: Springer.
59. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
60. Gerhard W, Mozdzanowska K, Zharikova D (2006) Prospects for universal influenza virus vaccine. Emerg Infect Dis 12: 569-574.
61. Carrat F, Flahault A (2007) Influenza vaccine: The challenge of antigenic drift. Vaccine 25: 6852-6862.
62. Fisher RA (1999) The genetical theory of natural selection. Oxford (UK): Oxford University Press. pp 318.
63. Ross R (1910) The prevention of malaria. New York: E.P. Dutton. pp 669.
64. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
65. Tria F, Lä ssig M, Peliti L, Franz S (2005) A minimal stochastic model for influenza evolution. J Stat Mech;doi:10.1088/1742-5468/2005/07/P07008.
66. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898-1903.